Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
72.00
-0.25 (-0.35%)
At close: Mar 13, 2026, 4:00 PM EDT
71.00
-1.00 (-1.39%)
After-hours: Mar 13, 2026, 7:14 PM EDT
Bright Minds Biosciences Employees
Bright Minds Biosciences had 26 employees as of September 30, 2025. The number of employees increased by 25 or 2,500.00% compared to the previous year.
Employees
26
Change (1Y)
25
Growth (1Y)
2,500.00%
Revenue / Employee
n/a
Profits / Employee
-$556,655
Market Cap
719.99M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 26 | 25 | 2,500.00% |
| Sep 30, 2024 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 579 |
| ProKidney | 204 |
| Prime Medicine | 146 |
| Theravance Biopharma | 97 |
| Lexicon Pharmaceuticals | 81 |
| AgomAb Therapeutics NV | 58 |
| Jade Biosciences | 55 |
DRUG News
- 16 days ago - Bright Minds Biosciences to Present at Upcoming Conferences - GlobeNewsWire
- 25 days ago - BTIG Maintains Buy Rating for Bright Minds Biosciences (DRUG) with $147 Target | DRUG Stock News - GuruFocus
- 2 months ago - Bright Minds Biosciences Announces Closing of US$175 Million Public Offering - GlobeNewsWire
- 2 months ago - Bright Minds Biosciences (DRUG) Prices $175M Public Offering - GuruFocus
- 2 months ago - Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock - GlobeNewsWire
- 2 months ago - Bright Minds Biosciences: Positive BREAKTHROUGH Study Data Warrants 'Strong Buy' Rating - Seeking Alpha
- 2 months ago - Bright Minds Biosciences, Praxis Precision Medicines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 2 months ago - Bright Minds Biosciences launches $100 million public offering - Seeking Alpha